NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine

Clinical trial NCT00199849 · COMPLETED

Trial details

NCT number: NCT00199849
Sponsor: Ludwig Institute for Cancer Research
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Bladder Cancer Non-small Cell Lung Cancer Esophageal Cancer Sarcoma

Start date: 2004-09-27
Primary completion: 2006-09-11
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.